Research Report: Human **ABI2** (Abl interactor 2) Functional Annotation Falcon Edison Scientific Literature 12 citations 2026-03-06T02:53:18.128888

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research Report: Human ABI2 (Abl interactor 2) Functional Annotation

Target verification: UniProt Q9NYB9; gene ABI2; organism Homo sapiens. ABI2 is an ABI-family adaptor protein with conserved HHR and SH3 domains and is a component of the WAVE regulatory complex (WRC). (petersen2024adaptorproteinabelson pages 7-8, han2023orchestrationofsynaptic media dd79d870)

Category Evidence Summary Key Sources URL
Identity & Domains Identified as UniProt Q9NYB9 (Abl interactor 2). Sequence identity to ABI1 is ~74%. Contains HHR (Hox homology region) and SH3 (Src homology 3) domains. Petersen & Dubielecka (2024) Cell Commun Signal; Han & Ko (2023) Exp Mol Med 10.1186/s12964-024-01738-z
Core Molecular Role Adaptor protein regulating actin cytoskeleton dynamics. Integral subunit of the WAVE regulatory complex (WRC) essential for activating Arp2/3-mediated actin nucleation. Han & Ko (2023); Jensen et al. (2023) J Cell Biol 10.1038/s12276-023-01004-1
Complexes & Partners Heteropentameric WAVE regulatory complex (WRC) component (with WAVE/Scar, CYFIP/SRA1, NCKAP1/NAP1, BRK1). Interacts with Abl/Arg kinases and PIM1 kinase. Han & Ko (2023); Jensen et al. (2023); Petersen & Dubielecka (2024) 10.1083/jcb.202208136
Localization Localizes to the plasma membrane and leading edge (lamellipodia) to drive protrusions; recruited/activated by Rac1. Jensen et al. (2023); Petersen & Dubielecka (2024) 10.1083/jcb.202208136
Recent 2023 Findings Identified as a novel substrate of PIM1 kinase (phosphorylated at Ser183). This phosphorylation stabilizes ABI2 (and WAVE2), promoting actin polymerization and tumor invasion under hypoxia. Jensen et al. (2023) J Cell Biol 10.1083/jcb.202208136
Quantitative Data Stability (Half-life): WT=3.2±0.3h; S183D (phospho-mimetic)=7.3±0.2h; PIM1 overexpression increases to 7.6h. Invasion: PIM1 loss (ABI2 regulator) decreases invasion depth ~11.2-fold. Jensen et al. (2023) 10.1083/jcb.202208136
Disease & Translation High ABI2 expression in prostate tumors correlates with biochemical recurrence. Loss of ABI2 reduces tumor size and muscle invasion in vivo. Linked to synaptic dysfunction in brain disorders. Jensen et al. (2023); Han & Ko (2023) 10.1083/jcb.202208136

Table: A summary of the key functional characteristics, interaction partners, and recent quantitative findings for the human ABI2 protein (UniProt Q9NYB9) based on 2023-2024 literature.

1) Key concepts and definitions (current understanding)

1.1 ABI2 as an adaptor (non-enzymatic) actin-regulatory protein

ABI2 (Abi-2) is a SH3-containing Abl interactor (an adaptor/scaffold rather than an enzyme), originally identified in the context of Abelson-family tyrosine kinases, and is implicated in actin-based cellular behaviors through multiprotein complexes. (petersen2024adaptorproteinabelson pages 22-23)

1.2 WAVE regulatory complex (WRC)

The WAVE regulatory complex (WRC) is a five-subunit assembly consisting of Cyfip/Sra1, WAVE/Scar, Abi (ABI1/2/3), Nap1/Nckap1, and Brk1/HSPC300; it is described as essential for actin cytoskeletal dynamics/remodeling and functions by linking upstream signaling to Arp2/3-mediated actin nucleation. (han2023orchestrationofsynaptic pages 1-2, jensen2023pim1phosphorylatesabi2 pages 1-2)

A central concept is that WRC is regulated (e.g., by Rac1 and phosphorylation), enabling WAVE to expose an activating element that recruits Arp2/3 to generate branched actin networks that support protrusions (e.g., lamellipodia) and other actin-dependent processes. (jensen2023pim1phosphorylatesabi2 pages 1-2)

1.3 Domain architecture (for functional inference)

A schematic of WRC subunits depicts Abi proteins (including ABI2) with a HHR (Hox homology region) and a C-terminal SH3 domain, consistent with adaptor-like functions (protein-binding and complex assembly) rather than catalytic activity. (han2023orchestrationofsynaptic media dd79d870)

2) Recent developments and latest research (prioritizing 2023–2024)

A 2023 mechanistic study reported that PIM1 phosphorylates ABI2 at Ser183, identifying ABI2 as a novel substrate of PIM kinases using a SILAC-based phosphoproteomics approach (the authors report identifying 75 potential PIM targets). (jensen2023pim1phosphorylatesabi2 pages 4-5)

Functionally, Ser183 phosphorylation was tied to ABI2 stability and downstream WRC behavior: in cycloheximide-chase assays of GFP-ABI2 variants, ABI2 half-life was WT 3.2 ± 0.3 h, S183D 7.3 ± 0.2 h (phospho-mimetic, increased stability), and S183A 1.8 ± 0.2 h (phospho-dead, decreased stability). (jensen2023pim1phosphorylatesabi2 pages 6-7)

PIM1 overexpression increased ABI2 stability (7.6 ± 0.3 h vs 3.1 ± 0.2 h, P < 0.05), and PIM1 knockout reduced it (2.0 ± 0.1 h), supporting a causal PIM1→ABI2 stabilization mechanism. (jensen2023pim1phosphorylatesabi2 pages 6-7)

In the same work, hypoxia increased ABI2 stability (4.4 ± 0.2 vs 2.9 ± 0.1 h), and this effect was reversed by PIM inhibition (PIM447 reduced ABI2 half-life to 1.7 ± 0.2 h), consistent with hypoxia engaging PIM activity upstream of ABI2. (jensen2023pim1phosphorylatesabi2 pages 6-7)

At the actin machinery level, the study linked ABI2 phosphorylation/stability to WRC/Arp2/3 outputs at the cell periphery (e.g., ARP3 signal at the leading edge). (jensen2023pim1phosphorylatesabi2 pages 6-7)

2.2 2023: WRC biology in neurons and synapses (review-level synthesis)

A 2023 review emphasized that the WRC (including ABI family members ABI1/ABI2/ABI3) orchestrates actin remodeling critical for neuronal and synaptic functions, and highlighted that WRC dysfunction is implicated in brain disorders. (han2023orchestrationofsynaptic pages 1-2)

2.3 2024: ABI-family contextualization and ABI2 identity/domain conservation

A 2024 review focusing on ABI1 provides comparative information for ABI family members and explicitly states ABI2 corresponds to UniProt Q9NYB9, reporting ~74% sequence identity between ABI2 and ABI1 and describing shared adaptor-like features. (petersen2024adaptorproteinabelson pages 7-8)

3) Current applications and real-world implementations

3.1 Cancer cell invasion/motility programs and pathway targeting (preclinical)

In prostate cancer models, PIM activity was tied to invasion phenotypes: genetic loss of PIM1 strongly reduced invasion depth with an ~11.2-fold decrease reported in one assay context, and pharmacologic PIM inhibition (e.g., AZD1208) blocked hypoxia-driven invasion increases. (jensen2023pim1phosphorylatesabi2 pages 2-3)

Because the same study mechanistically places ABI2 as a PIM substrate whose phosphorylation stabilizes ABI2 and supports WRC/actin outputs, ABI2 sits in a drug-targetable signaling→cytoskeleton axis (PIM kinases are the tractable node in the cited work). (jensen2023pim1phosphorylatesabi2 pages 6-7, jensen2023pim1phosphorylatesabi2 pages 4-5)

3.2 Experimental/analytical implementations used to interrogate ABI2 function

Recent work operationalizes ABI2 function through: (i) phosphoproteomics to identify ABI2 as a kinase substrate; (ii) cycloheximide-chase to quantify stability effects of phosphosite mutants; and (iii) live-cell imaging (Lifeact-based protrusion quantification) and 3D invasion assays to connect biochemical regulation to protrusion/invasion phenotypes. (jensen2023pim1phosphorylatesabi2 pages 1-2, jensen2023pim1phosphorylatesabi2 pages 2-3, jensen2023pim1phosphorylatesabi2 pages 4-5)

4) Expert opinions and authoritative analysis

4.1 ABI2 as a WRC subunit linking upstream signals to actin nucleation

Authoritative review synthesis describes the WRC as a key signal integration machine that couples upstream cues (notably small GTPases such as Rac1) to Arp2/3-dependent actin branching, and explicitly places ABI2 as one of the Abi-family choices used as the WRC “Abi” subunit. (han2023orchestrationofsynaptic pages 1-2, jensen2023pim1phosphorylatesabi2 pages 1-2)

4.2 ABI2/ABI family compensatory relationships (expert review perspective)

Review-level analysis notes that ABI2 likely overlaps functionally with ABI1 in certain contexts (including ABL-related signaling), and that ABI2 may increase when ABI1 is lost, consistent with compensatory capacity within the ABI family. (petersen2024adaptorproteinabelson pages 7-8)

5) Relevant statistics and recent data highlights

5.1 Quantitative molecular regulation (ABI2 stability)

Key 2023 quantitative results for ABI2 regulation by phosphorylation at Ser183 include: WT half-life 3.2 ± 0.3 h; phospho-mimetic S183D 7.3 ± 0.2 h; phospho-dead S183A 1.8 ± 0.2 h; PIM1 overexpression 7.6 ± 0.3 h vs 3.1 ± 0.2 h; hypoxia 4.4 ± 0.2 vs 2.9 ± 0.1 h; PIM inhibition (PIM447) 1.7 ± 0.2 h. (jensen2023pim1phosphorylatesabi2 pages 6-7)

5.2 Quantitative invasion phenotype (upstream PIM dependence)

A reported effect size connecting the pathway to invasion is an ~11.2-fold decrease in invasion depth upon PIM1 knockout in prostate cancer model experiments, supporting that this signaling axis has large impact on invasive behavior. (jensen2023pim1phosphorylatesabi2 pages 2-3)

5.3 Quantitative identity/comparative metrics

ABI2 is explicitly mapped to UniProt Q9NYB9, and ABI2 shares ~74% sequence identity with ABI1 per a 2024 review, supporting close paralogy and conserved domain architecture. (petersen2024adaptorproteinabelson pages 7-8)

Cellular localization and pathway placement (consolidated functional annotation)

Localization (where ABI2 acts)

Available evidence supports ABI2 acting predominantly in the cytoplasmic cortical actin system as part of the WRC that translocates to the plasma membrane/leading edge to enable Arp2/3-dependent actin remodeling. (jensen2023pim1phosphorylatesabi2 pages 1-2, jensen2023pim1phosphorylatesabi2 pages 6-7)

Pathway context (how ABI2 is regulated and what it regulates)

A well-supported pathway segment from recent literature is: hypoxia → increased PIM kinase activity/levels → ABI2 Ser183 phosphorylation → increased ABI2 stability → increased WRC function (including WAVE2 behavior) → enhanced Arp2/3-associated actin dynamics → increased protrusion and invasion in prostate cancer models. (jensen2023pim1phosphorylatesabi2 pages 6-7, jensen2023pim1phosphorylatesabi2 pages 2-3, jensen2023pim1phosphorylatesabi2 pages 4-5)

Disease associations (curated resources + experimental work)

Curated disease-target association resources (Open Targets) list ABI2 associations spanning categories including neoplasm and neurodegenerative disease (summary-level association evidence). (petersen2024adaptorproteinabelson pages 7-8)

Experimental cancer evidence from 2023 indicates ABI2 is relevant to invasive tumor behavior: ABI2 knockout reduced invasion and was associated with smaller tumors in vivo in the cited models, aligning ABI2/WRC biology with tumor progression phenotypes. (jensen2023pim1phosphorylatesabi2 pages 10-11)

Key sources (with publication dates and URLs)

  1. Jensen CC et al. “PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion.” Journal of Cell Biology. Apr 2023. https://doi.org/10.1083/jcb.202208136 (jensen2023pim1phosphorylatesabi2 pages 6-7, jensen2023pim1phosphorylatesabi2 pages 2-3)
  2. Han KA & Ko J. “Orchestration of synaptic functions by WAVE regulatory complex-mediated actin reorganization.” Experimental & Molecular Medicine. Jun 2023. https://doi.org/10.1038/s12276-023-01004-1 (han2023orchestrationofsynaptic pages 1-2, han2023orchestrationofsynaptic media dd79d870)
  3. Petersen M & Dubielecka P. “Adaptor protein Abelson interactor 1 in homeostasis and disease.” Cell Communication and Signaling. Oct 2024. https://doi.org/10.1186/s12964-024-01738-z (petersen2024adaptorproteinabelson pages 7-8, petersen2024adaptorproteinabelson pages 22-23)

Scope limitations (evidence-bound)

This report is constrained to statements directly supported by retrieved 2023–2024 reviews and a 2023 mechanistic study; several broader ABI2 topics (e.g., detailed isoform-specific localization, comprehensive interactome mapping beyond WRC/PIM/ABL framing, and human Mendelian genetics) are likely documented in additional primary literature not retrieved in the current tool session. (han2023orchestrationofsynaptic pages 1-2, jensen2023pim1phosphorylatesabi2 pages 6-7)

References

  1. (petersen2024adaptorproteinabelson pages 7-8): Max Petersen and Pat Dubielecka. Adaptor protein abelson interactor 1 in homeostasis and disease. Cell Communication and Signaling : CCS, Oct 2024. URL: https://doi.org/10.1186/s12964-024-01738-z, doi:10.1186/s12964-024-01738-z. This article has 0 citations.

  2. (han2023orchestrationofsynaptic media dd79d870): Kyung Ah Han and Jaewon Ko. Orchestration of synaptic functions by wave regulatory complex-mediated actin reorganization. Experimental & Molecular Medicine, 55:1065-1075, Jun 2023. URL: https://doi.org/10.1038/s12276-023-01004-1, doi:10.1038/s12276-023-01004-1. This article has 31 citations and is from a peer-reviewed journal.

  3. (petersen2024adaptorproteinabelson pages 22-23): Max Petersen and Pat Dubielecka. Adaptor protein abelson interactor 1 in homeostasis and disease. Cell Communication and Signaling : CCS, Oct 2024. URL: https://doi.org/10.1186/s12964-024-01738-z, doi:10.1186/s12964-024-01738-z. This article has 0 citations.

  4. (han2023orchestrationofsynaptic pages 1-2): Kyung Ah Han and Jaewon Ko. Orchestration of synaptic functions by wave regulatory complex-mediated actin reorganization. Experimental & Molecular Medicine, 55:1065-1075, Jun 2023. URL: https://doi.org/10.1038/s12276-023-01004-1, doi:10.1038/s12276-023-01004-1. This article has 31 citations and is from a peer-reviewed journal.

  5. (jensen2023pim1phosphorylatesabi2 pages 1-2): Corbin C. Jensen, Amber N. Clements, Hope Liou, Lauren E. Ball, Jennifer R. Bethard, Paul R. Langlais, Rachel K. Toth, Shailender S. Chauhan, Andrea L. Casillas, Sohail R. Daulat, Andrew S. Kraft, Anne E. Cress, Cindy K. Miranti, Ghassan Mouneimne, Greg C. Rogers, and Noel A. Warfel. Pim1 phosphorylates abi2 to enhance actin dynamics and promote tumor invasion. The Journal of Cell Biology, Apr 2023. URL: https://doi.org/10.1083/jcb.202208136, doi:10.1083/jcb.202208136. This article has 13 citations.

  6. (jensen2023pim1phosphorylatesabi2 pages 4-5): Corbin C. Jensen, Amber N. Clements, Hope Liou, Lauren E. Ball, Jennifer R. Bethard, Paul R. Langlais, Rachel K. Toth, Shailender S. Chauhan, Andrea L. Casillas, Sohail R. Daulat, Andrew S. Kraft, Anne E. Cress, Cindy K. Miranti, Ghassan Mouneimne, Greg C. Rogers, and Noel A. Warfel. Pim1 phosphorylates abi2 to enhance actin dynamics and promote tumor invasion. The Journal of Cell Biology, Apr 2023. URL: https://doi.org/10.1083/jcb.202208136, doi:10.1083/jcb.202208136. This article has 13 citations.

  7. (jensen2023pim1phosphorylatesabi2 pages 6-7): Corbin C. Jensen, Amber N. Clements, Hope Liou, Lauren E. Ball, Jennifer R. Bethard, Paul R. Langlais, Rachel K. Toth, Shailender S. Chauhan, Andrea L. Casillas, Sohail R. Daulat, Andrew S. Kraft, Anne E. Cress, Cindy K. Miranti, Ghassan Mouneimne, Greg C. Rogers, and Noel A. Warfel. Pim1 phosphorylates abi2 to enhance actin dynamics and promote tumor invasion. The Journal of Cell Biology, Apr 2023. URL: https://doi.org/10.1083/jcb.202208136, doi:10.1083/jcb.202208136. This article has 13 citations.

  8. (jensen2023pim1phosphorylatesabi2 pages 2-3): Corbin C. Jensen, Amber N. Clements, Hope Liou, Lauren E. Ball, Jennifer R. Bethard, Paul R. Langlais, Rachel K. Toth, Shailender S. Chauhan, Andrea L. Casillas, Sohail R. Daulat, Andrew S. Kraft, Anne E. Cress, Cindy K. Miranti, Ghassan Mouneimne, Greg C. Rogers, and Noel A. Warfel. Pim1 phosphorylates abi2 to enhance actin dynamics and promote tumor invasion. The Journal of Cell Biology, Apr 2023. URL: https://doi.org/10.1083/jcb.202208136, doi:10.1083/jcb.202208136. This article has 13 citations.

  9. (jensen2023pim1phosphorylatesabi2 pages 10-11): Corbin C. Jensen, Amber N. Clements, Hope Liou, Lauren E. Ball, Jennifer R. Bethard, Paul R. Langlais, Rachel K. Toth, Shailender S. Chauhan, Andrea L. Casillas, Sohail R. Daulat, Andrew S. Kraft, Anne E. Cress, Cindy K. Miranti, Ghassan Mouneimne, Greg C. Rogers, and Noel A. Warfel. Pim1 phosphorylates abi2 to enhance actin dynamics and promote tumor invasion. The Journal of Cell Biology, Apr 2023. URL: https://doi.org/10.1083/jcb.202208136, doi:10.1083/jcb.202208136. This article has 13 citations.

Citations

  1. petersen2024adaptorproteinabelson pages 22-23
  2. han2023orchestrationofsynaptic pages 1-2
  3. petersen2024adaptorproteinabelson pages 7-8
  4. 10.1186/s12964-024-01738-z
  5. 10.1038/s12276-023-01004-1
  6. 10.1083/jcb.202208136
  7. https://doi.org/10.1186/s12964-024-01738-z
  8. https://doi.org/10.1038/s12276-023-01004-1
  9. https://doi.org/10.1083/jcb.202208136
  10. https://doi.org/10.1186/s12964-024-01738-z,
  11. https://doi.org/10.1038/s12276-023-01004-1,
  12. https://doi.org/10.1083/jcb.202208136,